Display options
Cite
Selvarajan S, George M, Kumar SS, et al. Clinical trials in India: Where do we stand globally?. Perspect Clin Res. 2013;4(3):160-4doi: 10.4103/2229-3485.115373.
Selvarajan, S., George, M., Kumar, S. S., & Dkhar, S. A. (2013). Clinical trials in India: Where do we stand globally?. Perspectives in clinical research, 4(3), 160-4. https://doi.org/10.4103/2229-3485.115373
Selvarajan, Sandhiya, et al. "Clinical trials in India: Where do we stand globally?." Perspectives in clinical research vol. 4,3 (2013): 160-4. doi: https://doi.org/10.4103/2229-3485.115373
Selvarajan S, George M, Kumar SS, Dkhar SA. Clinical trials in India: Where do we stand globally?. Perspect Clin Res. 2013 Jul;4(3):160-4. doi: 10.4103/2229-3485.115373. PMID: 24010056; PMCID: PMC3757579.
Copy Download .nbib Format: NLM
Share it on

Perspect Clin Res. 2013 Jul;4(3):160-4. doi: 10.4103/2229-3485.115373.

Clinical trials in India: Where do we stand globally?.

Perspectives in clinical research

Sandhiya Selvarajan, Melvin George, Suresh S Kumar, Steven Aibor Dkhar

Affiliations

  1. Department of Clinical Pharmacology, JIPMER, Puducherry, India.

PMID: 24010056 PMCID: PMC3757579 DOI: 10.4103/2229-3485.115373

Abstract

AIMS: To evaluate the trend of clinical trials in India over the last 4 years compared to the well-established countries using clinical trial registries since the advent of clinical trial registry of India (CTRI).

MATERIALS AND METHODS: The data of clinical trials registered in India, United States (US), and European Union (EU) were obtained from websites of CTRI, clinicaltrial.gov and EU clinical trial registry, respectively from July 20, 2007 to August 29, 2011 for a period of 4 years. Trials registered in Australia, Canada, China, and Japan were obtained from WHO's international clinical trial registry platform for the same period. We used search words for the common diseases such as diabetes, hypertension, etc..

RESULTS: The total number of clinical trials registered during the study period was 67,448 across seven study nations. Clinical trials from India constituted only 2.7% of the total number of trials carried out, compared to US constituting 47% of the total number of trials registered, followed by 18% from EU and 11% from Japan. However, India, China, and Japan have been found to show an increase of 3.7%, 5.1%, and 13.1% increase in the number of trials registered in 2011 compared to 2007. In contrast, US and EU showed a decline of 11.3% and 11.95% respectively in the total number of trials registered in 2011 compared to 2007.

CONCLUSIONS: Although India shows gradual increase in trials registered since the advent of CTRI, still it continues to lag behind established countries in clinical research.

Keywords: Clinical trial registry of India; global clinical trials; world health organization's international clinical trial registry platform

References

  1. Indian J Pharmacol. 2008 Mar;40(2):47-8 - PubMed
  2. Indian J Pharm Sci. 2010 Sep;72(5):546-56 - PubMed
  3. Nature. 2011 Jan 27;469(7331):478-9 - PubMed
  4. Lipids Health Dis. 2008 Oct 24;7:40 - PubMed
  5. PLoS One. 2010 Dec 16;5(12):e14368 - PubMed
  6. Trends Pharmacol Sci. 2011 Jun;32(6):327-9 - PubMed
  7. N Engl J Med. 2009 Feb 19;360(8):816-23 - PubMed
  8. Indian J Med Res. 2009 Jul;130(1):85-6 - PubMed
  9. Indian J Cancer. 2008 Jul-Sep;45(3):79-82 - PubMed
  10. Rev Assoc Med Bras (1992). 2010 Jul-Aug;56(4):428-33 - PubMed

Publication Types